Summary
Terumo BCT Inc (Terumo BCT), a subsidiary of Terumo Corp, provides blood components, therapeutic apheresis, and cellular technologies. The company's key products include an automated blood collection system, information system, data collection system, apheresis system, cell processor, cell separation system, pathogen reduction technology system, whole blood processing system, cell expansion system, orbisac system, sterile tubing welder, tube sealing device, blood bag system, and ancillary products for blood centers. Its technologies and systems are used in immunotherapy, gene therapy, and cell therapy. Terumo BCT serves blood centers, cell collection, and processing organizations, hospitals, therapeutic apheresis clinics, researchers, and private medical practices. The company has manufacturing facilities in India, Japan, Belgium, Northern Ireland, Vietnam, and the US; and sells products the world over through subsidiaries and offices. Terumo BCT is headquartered in Lakewood, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Terumo BCT Inc (Terumo BCT), a subsidiary of Terumo Corp, provides blood components, therapeutic apheresis, and cellular technologies. The company's key products include an automated blood collection system, information system, data collection system, apheresis system, cell processor, cell separation system, pathogen reduction technology system, whole blood processing system, cell expansion system, orbisac system, sterile tubing welder, tube sealing device, blood bag system, and ancillary products for blood centers. Its technologies and systems are used in immunotherapy, gene therapy, and cell therapy. Terumo BCT serves blood centers, cell collection, and processing organizations, hospitals, therapeutic apheresis clinics, researchers, and private medical practices. The company has manufacturing facilities in India, Japan, Belgium, Northern Ireland, Vietnam, and the US; and sells products the world over through subsidiaries and offices. Terumo BCT is headquartered in Lakewood, Colorado, the US.
This report is a source for data, analysis, and actionable intelligence on the company's portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Terumo BCT Inc
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design , trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors' pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Terumo BCT Inc Company Overview
- Terumo BCT Inc Company Snapshot
- Terumo BCT Inc Pipeline Products and Ongoing Clinical Trials Overview
- Terumo BCT Inc - Pipeline Analysis Overview
- Business Description
- Terumo BCT Inc - Key Facts
- Terumo BCT Inc - Major Products and Services
- Terumo BCT Inc Pipeline Products by Development Stage
- Terumo BCT Inc Pipeline Products Overview
- Mirasol Pathogen Reduction Technology System - Platelets & Plasma
- Mirasol Pathogen Reduction Technology System - Platelets & Plasma Product Overview
- Mirasol Pathogen Reduction Technology System - Whole Blood
- Mirasol Pathogen Reduction Technology System - Whole Blood Product Overview
- Plasmapheresis Device
- Plasmapheresis Device Product Overview
- Terumo BCT Inc - Key Competitors
- Terumo BCT Inc - Key Employees
- Terumo BCT Inc - Key Employee Biographies
- Terumo BCT Inc - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Terumo BCT Inc, Recent Developments
- Dec 04, 2019: Spectra Optia apheresis: anticoagulant bags used with ‘Correct Connect’ connectors - risk of unbroken ‘frangible’ connector during use (MDA/2019/041)
- Oct 02, 2019: Terumo BCT launches first-of-its-kind device to accelerate cell therapy manufacturing
- Apr 01, 2019: New CEO leads Terumo BCT's ambition to shape the future of blood and cell technologies in healthcare
- Oct 15, 2018: Terumo: Grant offered to impact patients and communities managing Sickle Cell Disease
- Aug 15, 2018: David Perez to retire as President and CEO of Terumo BCT on March 31, 2019; Antoinette Gawin named successor
- May 17, 2018: Mirasol-Treated Platelets Show No Clinical Difference in Reducing Bleeding From Conventional Platelets in Plasma
- Apr 30, 2018: First U.S. Clinical Trial Evaluating Red Blood Cells Derived From Pathogen-Reduced Whole Blood Begins
- Feb 24, 2018: New Collaboration with StafaCT Will Optimize Patient Pathways for Cellular Treatments
- Dec 06, 2017: The Department of Defense Awards Terumo BCT Grant to Explore Feasibility of Next-Generation Mirasol
- Oct 10, 2017: Terumo BCT Selects Windchill Quality Management to Enhance Global Quality Processes
- Appendix
- Methodology
- About the Analyst
- Contact the Analyst
- Disclaimer
- Terumo BCT Inc Pipeline Products and Ongoing Clinical Trials Overview
- Terumo BCT Inc Pipeline Products by Equipment Type
- Terumo BCT Inc Pipeline Products by Indication
- Terumo BCT Inc, Key Facts
- Terumo BCT Inc, Major Products and Services
- Terumo BCT Inc Number of Pipeline Products by Development Stage
- Terumo BCT Inc Pipeline Products Summary by Development Stage
- Mirasol Pathogen Reduction Technology System - Platelets & Plasma - Product Status
- Mirasol Pathogen Reduction Technology System - Platelets & Plasma - Product Description
- Mirasol Pathogen Reduction Technology System - Whole Blood - Product Status
- Mirasol Pathogen Reduction Technology System - Whole Blood - Product Description
- Plasmapheresis Device - Product Status
- Plasmapheresis Device - Product Description
- Terumo BCT Inc, Key Employees
- Terumo BCT Inc, Key Employee Biographies
- Terumo BCT Inc, Other Locations
- Terumo BCT Inc, Subsidiaries
- Glossary
- Terumo BCT Inc Pipeline Products by Equipment Type
- Terumo BCT Inc Pipeline Products by Development Stage
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- GE HealthCare Technologies Inc
- Sartorius AG
- Guerbet SA
- Haemonetics Corp
- Sotera Health Co
- FL MEDICAL srl
